Trials / Completed
CompletedNCT00233649
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine in DM II patients the efficacy of Crestor in obtaining the new European LDL cholesterol guidelines.
Conditions
Timeline
- Start date
- 2004-05-01
- First posted
- 2005-10-06
- Last updated
- 2010-11-19
Locations
222 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00233649. Inclusion in this directory is not an endorsement.